Literature DB >> 18647449

Risk of tuberculosis in screened subjects without known risk factors for active disease.

V J Cook1, E Hernández-Garduño, R K Elwood.   

Abstract

SETTING: Tuberculosis (TB) referral clinic in Vancouver, British Columbia, Canada.
BACKGROUND: Screening for and treatment of latent TB infection (LTBI) in at-risk populations are the cornerstone of TB control in low-incidence countries. Persons at low risk often undergo the tuberculin skin test (TST) for reasons other than contact. Little information exists on the actual risk of TB in this population.
OBJECTIVE: To determine the risk of TB in screened subjects without known risk factors.
DESIGN: Retrospective descriptive analysis of demographics, TST reaction size and TB disease occurrence in 98333 low-risk subjects screened from 1990 to 2002.
RESULTS: The average annual disease rate was 0.4 per 100000 population (cumulative rate 7.4/100000) from 1990 to 2006, and TB was diagnosed only in the foreign-born. Risk of TB in the foreign-born increased with larger TST reaction size (P < 0.03). Completion of treatment for LTBI was not documented for any of the subsequent active TB cases.
CONCLUSION: In a low-risk screened population, active TB disease was found only in the foreign-born. Treatment of LTBI is not recommended in persons with a positive TST and no additional risk factors. Local screening programs should focus on populations with confirmed risk factors for disease.

Entities:  

Mesh:

Year:  2008        PMID: 18647449

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  2 in total

1.  Management of latent tuberculous infection in Norway in 2009: a descriptive cross-sectional study.

Authors:  A I M Olsen; H E Andersen; J Aßmus; J A Djupvik; G Gran; K Skaug; O Mørkve
Journal:  Public Health Action       Date:  2013-06-21

2.  An exploration of NHS staff views on tuberculosis service delivery in Scottish NHS boards.

Authors:  Leah Mtui; William Spence
Journal:  J Infect Prev       Date:  2013-08-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.